サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555494

手術部位感染対策市場：製品別、手術/手技別、感染タイプ別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Surgical Site Infection Control Market, By Product, By Surgery/Procedure, By Type of Infection, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
手術部位感染対策市場：製品別、手術/手技別、感染タイプ別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

手術部位感染対策市場規模は2023年に36億6,550万米ドルと評価され、2024年から2032年にかけてCAGR 5.50％で拡大

手術部位感染対策市場-市場力学

手術件数の増加

手術部位感染対策市場の成長を後押しする主な要因の1つは、世界的に手術件数が増加していることです。予防技術の躍進にもかかわらず、手術部位感染（SSI）は依然として、美容整形手術や外来外科的介入を受ける入院患者に発生する最も一般的な有害事象の一つです。さらに、SSIは術後手術を受けた患者の中で最も頻度の高い合併症です。SSIは高い死亡率、かなりの罹患率、そして患者個人と国家予算の両方に対する高額な負担につながります。手術部位感染（SSI）は、手術後30～90日までの患者に発症する感染症として説明されます。SSIは、切開部位だけでなく、手術部位周辺の深部組織にも影響を及ぼします。

手術部位感染対策市場-主要インサイト

当社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約5.50%のCAGRで毎年成長すると予測されています。

製品セグメンテーションに基づくと、手術用手袋カテゴリは2023年に最大市場シェアを示すと予測されました。

手術/手技のセグメンテーションでは、帝王切開のカテゴリーが2023年に最大の市場シェアを示すと予測されました。

感染タイプ別では、表面切開SSIカテゴリーが2023年に最大の市場シェアを示すと予測されました。

エンドユーザーセグメンテーションに基づくと、2023年には病院カテゴリーが主要セグメントとなった。

地域別では、北米が2023年の売上高でトップ

手術部位感染対策市場-セグメンテーション分析：

世界の手術部位感染対策市場は、製品、手術／手技、感染タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場は手術／処置に基づいて以下のカテゴリーに分けられる：白内障手術、帝王切開、歯科修復、胃バイパス、その他の手術／処置。帝王切開のカテゴリーが市場を独占しています。世界中で最も広く行われている外科手術のひとつが帝王切開です。帝王切開による出産の件数は、時間の経過とともにいくつかの国で徐々に増加しています。帝王切開が非常に多く行われているため、SSI予防は感染管理イニシアチブの主要な重点分野となっています。さらに、帝王切開の手術部位は、さまざまな細菌が生息する消化管や腟に近いため、特に感染しやすいです。さらに、治療には表皮や子宮壁の天然バリアを破壊する必要があるため、感染の可能性が高くなります。

市場は感染のタイプによって以下のカテゴリーに分けられる：表在性切開創SSI、深在性切開創SSI、臓器・腔内SSIです。表在性切開創SSIカテゴリーが市場を独占しており、予測期間中もその優位性を維持するとみられます。切開創周囲の皮膚と皮下組織のみがこれらの感染症に冒され、処置の30日後に発症します。手術部位の発赤、温感、腫脹、局所的な不快感などの症状が頻繁に現れます。これらは外科診療で見られる最も典型的なSSIの一部です。その相対的な有病率は、感染制御の試みにとっていかに重要であるかを強調しています。例えば、2023年の米国国立医学図書館の発表によると、SSI患者の59％が表在性SSIでした。

手術部位感染対策市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分けられます。

予測期間中、北米が手術部位感染対策の世界市場で最大のシェアを占めると予想されます。抗菌剤、手術用ドレープ、手袋、滅菌用品、創傷ケア用品、モニタリングシステムなどは、SSI対策産業の一翼を担う数多くの製品のほんの一部に過ぎないです。北米の病院では、手術方法や感染管理手順の改善にもかかわらず、手術部位感染（SSI）が依然として大きな問題となっています。SSIの発生頻度は外科の専門分野や環境によって異なるが、それでもSSIはヘルスケアシステムに臨床的にも財政的にも大きな負担をかけています。

また、手術部位感染対策市場は、予測期間中にアジア太平洋地域で世界最速の速度で拡大すると予測されています。同市場は、低侵襲手術に対する需要の高まりや、ヘルスケア環境における手術部位感染対策技術の幅広い用途など、多くの要因から、予測期間中に中国やインドなどの新興国で拡大すると予想されます。中国とインドには、世界でもトップクラスの医療技術ビジネスがあると言われています。インドの医療技術企業Healthium MedTechは、2021年10月に独自の感染防止技術を備えた独創的な手術用創傷被覆材を発表したばかりです。

手術部位感染管理市場-競合情勢：

手術部位感染管理市場は、断片化が特徴です。手術部位感染管理市場の主要参入企業には、ジョンソン・エンド・ジョンソン、Getinge Group、Biomerieux SA、Becton, Dickinson, and Company、3M Companyなどがあります。世界の製品の進歩が続いているため、調査対象市場内の競合は激化しています。

目次

第1章 手術部位感染対策市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 手術部位感染対策の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 手術部位感染対策産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 手術部位感染対策市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 手術部位感染対策市場情勢

  • 手術部位感染対策市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 手術部位感染対策市場- 製品別

  • 概要
    • 製品別セグメントシェア分析
    • 手動再処理ソリューション
    • 消毒剤
      • 手指消毒剤
      • 皮膚消毒剤
    • 手術用スクラブ
    • バリカン
    • 手術用ドレープ
    • 外科的灌流
    • スキンプレパレーションソリューション
    • 医療用不織布
    • 手術用手袋
    • その他の製品

第8章 手術部位感染対策市場- 手術/手技別

  • 概要
    • 手術/手技別セグメントシェア分析
    • 白内障手術
    • 帝王切開
    • 歯科修復
    • 胃バイパス
    • その他の手術/手技

第9章 手術部位感染対策市場- 感染タイプ別

  • 概要
    • 感染タイプ別のセグメントシェア分析
    • 浅切開SSI
    • 深切開SSI
    • 臓器またはスペースSSI

第10章 手術部位感染対策市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 外来手術センター

第11章 手術部位感染対策市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 手術部位感染対策業界

  • 競合ダッシュボード
  • 企業プロファイル
    • 3M
    • Becton, Dickinson and Company
    • Belimed AG
    • Getinge Group
    • Johnson &Johnson
    • Kimberly-Clark Corporation
    • Sotera Health
    • Ansell Limited
    • Steris Corporation
    • Lac-Mac Limited
    • Pacon Manufacturing Corp.
    • American Polyfilm Inc.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV3569

REPORT HIGHLIGHT

Surgical Site Infection Control Market size was valued at USD 3,665.5 Million in 2023, expanding at a CAGR of 5.50% from 2024 to 2032.

An infection at the surgical site is referred to as a surgical site infection. After surgery is performed on the affected body part, an infection develops. Surgical infections can range in severity from minor infections that affect the skin to major infections that affect the body's organs. When dangerous bacteria get into a cut or incision, infections grow. This is where surgery site infection management becomes necessary. Medical gadgets, protocols, and recommendations specifically developed to combat the infection can be employed. Furthermore, these infections have the potential to become fatal if not properly treated in a timely manner. The main reason for the increase in demand for surgical site infection management is the world's growing population combined with an increase in surgical operations. Globally increasing accidents have resulted in an increase in medical procedures, which has raised the need for surgical site infection management. In addition, the need for antimicrobial interventions, such as antiseptics and disinfectants, is growing because of the rise in outpatient surgical operations. These procedures do not require overnight hospital stays, and patients may become infected when they are exposed to non-healthcare environments. Therefore, taking into account the benefits of outpatient surgery, such as increased convenience and lower costs, will sustain market expansion over the projected time.

Surgical Site Infection Control Market- Market Dynamics

Growing Number of Surgical Procedures

One of the main factors propelling the growth of the surgical site infection control market is the growing number of surgical procedures performed globally. Despite breakthroughs in preventive techniques, surgical site infections (SSIs) remain among the most prevalent adverse events that occur in hospitalized patients undergoing aesthetic surgery or outpatient surgical interventions. Additionally, SSIs are the most frequent complication among patients who have undergone postoperative surgery. They are linked to high rates of mortality, considerable morbidity, and expensive strain on both individual patients and the nation's budget. Surgical site infections (SSIs) are described as infections that develop in patients up to 30 to 90 days following surgery. They impact the deeper tissues surrounding the surgical site as well as the incisional site.

Surgical Site Infection Control Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.50% over the forecast period (2024-2032)

Based on product segmentation, the surgical gloves category was predicted to show maximum market share in the year 2023

Based on surgery/procedure segmentation, the cesarean section category was predicted to show maximum market share in the year 2023

Based on type of infection segmentation, the superficial incisional SSI category was predicted to show maximum market share in the year 2023

Based on end user segmentation, the hospitals category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Surgical Site Infection Control Market- Segmentation Analysis:

The Global Surgical Site Infection Control Market is segmented on the basis of Product, Surgery/Procedure, Type of Infection, End User, and Region.

The market is divided into the following categories based on surgery/procedure: Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass, and Other Surgeries/Procedures. The cesarean section category dominates the market. One of the most prevalent surgical procedures performed worldwide is the cesarean section. The number of C-section births has been gradually rising in several nations over time. Because there are so many C-sections performed, SSI prevention becomes a major area of focus for infection control initiatives. Furthermore, because the surgical site of a Cesarean section is close to the gastrointestinal and vaginal tracts, which are home to a variety of bacteria, it is especially susceptible to infection. Furthermore, there is a higher chance of infection because the treatment entails breaking down the epidermis and uterine wall's natural barriers.

The market is divided into the following categories based on type of infection: Superficial Incisional SSI, Deep Incisional SSI, and Organ or Space SSI. The superficial incisional SSI category dominates the market and is likely to maintain its dominance during the forecast period. Only the skin and subcutaneous tissue around the incision are affected by these infections, which appear 30 days after the procedure. Symptoms including redness, warmth, swelling, and localized discomfort at the surgery site are frequently present. These are some of the most typical SSIs that are seen in surgical practice. Their relative prevalence emphasizes how crucial they are to attempts to control infections. For instance, 59% of all SSI patients had superficial SSI, according to a 2023 National Library of Medicine publication.

Surgical Site Infection Control Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Surgical Site Infection Control. Antimicrobial agents, surgical drapes, gloves, sterilizing supplies, wound care items, and monitoring systems are just a few of the many products that are part of the SSI control industry. In North American hospitals, surgical site infections (SSIs) continue to be a major concern despite improvements in surgical methods and infection control procedures. While the frequency of SSIs varies among surgical specialties and environments, they nonetheless place a significant clinical and financial strain on healthcare systems.

In addition, the Surgical Site Infection Control market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The market is expected to increase in emerging nations like China and India during the forecast period due to a number of factors, including the increasing demand for minimally invasive operations and the wide variety of uses of surgical site infection control technologies in healthcare settings. China and India are reportedly home to some of the top MedTech businesses worldwide. Healthium MedTech, an Indian medical technology business, just unveiled in October 2021 an inventive surgical wound dressing with unique infection prevention technology.

Surgical Site Infection Control Market- Competitive Landscape:

The market for surgical site infection management is characterized by fragmentation. Some major participants in the surgical site infection control market are Johnson & Johnson, Getinge Group, Biomerieux SA, Becton, Dickinson, and Company, and 3M Company. Due to the ongoing global product advancements, the competitive competition within the market under investigation has become more intense.

Recent Developments:

February 2024: Following the enrollment of its 100th patient, PolyPid Ltd., a biopharmaceutical business committed to enhancing surgical outcomes, reported significant advancements in its SHIELD II Phase 3 clinical study. The purpose of this study was to evaluate the effectiveness of D-PLEX100, a product candidate designed to reduce the risk of surgical site infections (SSIs) during surgeries involving the colorectal region.

October 2023: The veteran-owned medical solutions company Spartan Medical Inc. launched a campaign to reduce the incidence of surgical site infections (SSls) in healthcare facilities across the country and increase public awareness of the condition. Spartan Medical, Inc., a leader in the field, is always addressing the problem of SSl prevention by using a two-pronged strategy. Providing cutting-edge sterile equipment and implants alongside superior wound care solutions was the strategy involved.

April 2022: Molnlycke built a new surgical glove facility in Malaysia as part of its expansion. To ensure it can continue to meet the rising demand for Biogel gloves, the business is expanding its manufacturing capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M
  • Becton, Dickinson and Company
  • Belimed AG
  • Getinge Group
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Sotera Health
  • Ansell Limited
  • Steris Corporation
  • Lac-Mac Limited
  • Pacon Manufacturing Corp.
  • American Polyfilm Inc.
  • Others

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Manual Reprocessors Solution
  • Disinfectants
  • Hand Disinfectants
  • Skin Disinfectants
  • Surgical Scrubs
  • Hair Clippers
  • Surgical Drapes
  • Surgical Irrigation
  • Skin Preparation Solution
  • Medical Nonwovens
  • Surgical Gloves
  • Other Products

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGERY/PROCEDURE- MARKET ANALYSIS, 2019 - 2032

  • Cataract Surgery
  • Cesarean Section
  • Dental Restoration
  • Gastric Bypass
  • Other Surgeries/Procedures

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION- MARKET ANALYSIS, 2019 - 2032

  • Superficial Incisional SSI
  • Deep Incisional SSI
  • Organ or Space SSI

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers

GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Surgical Site Infection Control Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Surgical Site Infection Control Market Snippet by Product
    • 2.1.2. Surgical Site Infection Control Market Snippet by Surgery/Procedure
    • 2.1.3. Surgical Site Infection Control Market Snippet by Type of Infection
    • 2.1.4. Surgical Site Infection Control Market Snippet by End User
    • 2.1.5. Surgical Site Infection Control Market Snippet by Country
    • 2.1.6. Surgical Site Infection Control Market Snippet by Region
  • 2.2. Competitive Insights

3. Surgical Site Infection Control Key Market Trends

  • 3.1. Surgical Site Infection Control Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Surgical Site Infection Control Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Surgical Site Infection Control Market Opportunities
  • 3.4. Surgical Site Infection Control Market Future Trends

4. Surgical Site Infection Control Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Surgical Site Infection Control Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Surgical Site Infection Control Market Landscape

  • 6.1. Surgical Site Infection Control Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Surgical Site Infection Control Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Manual Reprocessors Solution
    • 7.1.3. Disinfectants
      • 7.1.3.1. Hand Disinfectants
      • 7.1.3.2. Skin Disinfectants
    • 7.1.4. Surgical Scrubs
    • 7.1.5. Hair Clippers
    • 7.1.6. Surgical Drapes
    • 7.1.7. Surgical Irrigation
    • 7.1.8. Skin Preparation Solution
    • 7.1.9. Medical Nonwovens
    • 7.1.10. Surgical Gloves
    • 7.1.11. Other Products

8. Surgical Site Infection Control Market - By Surgery/Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Surgery/Procedure, 2023 & 2032 (%)
    • 8.1.2. Cataract Surgery
    • 8.1.3. Cesarean Section
    • 8.1.4. Dental Restoration
    • 8.1.5. Gastric Bypass
    • 8.1.6. Other Surgeries/Procedures

9. Surgical Site Infection Control Market - By Type of Infection

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type of Infection, 2023 & 2032 (%)
    • 9.1.2. Superficial Incisional SSI
    • 9.1.3. Deep Incisional SSI
    • 9.1.4. Organ or Space SSI

10. Surgical Site Infection Control Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers

11. Surgical Site Infection Control Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Surgical Site Infection Control Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Surgical Site Infection Control Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Surgical Site Infection Control Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Surgical Site Infection Control Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Surgical Site Infection Control Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Surgery/Procedure, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Type of Infection, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Surgical Site Infection Control Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. 3M
    • 12.2.2. Becton, Dickinson and Company
    • 12.2.3. Belimed AG
    • 12.2.4. Getinge Group
    • 12.2.5. Johnson & Johnson
    • 12.2.6. Kimberly-Clark Corporation
    • 12.2.7. Sotera Health
    • 12.2.8. Ansell Limited
    • 12.2.9. Steris Corporation
    • 12.2.10. Lac-Mac Limited
    • 12.2.11. Pacon Manufacturing Corp.
    • 12.2.12. American Polyfilm Inc.
    • 12.2.13. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us